AI-generated summary
The authors studied photobiomodulation therapy (red light at 660 nm) in mice with bleomycin-induced lung fibrosis. They report that treatment reduced inflammatory cells, collagen production, interstitial thickening, and lung elastance, as well as some inflammatory signals released by cultured cells. The study was conducted in mice and cell cultures, so these findings may not apply directly to humans.
- Who or what was studied
- C57BL6 mice with bleomycin-induced lung fibrosis, plus cultured pneumocytes and fibroblasts
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study used an animal model and cell cultures, and the abstract does not state the number of animals per group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 5 J/cm2
- Power density (irradiance)
- 33.3 mW/cm2
- Power
- 100 mW
- Total energy
- 15 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Collagen, Irradiance, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.